On paper, most hospice pharmacy providers describe similar capabilities: medication delivery, formulary support, clinical guidance. The real differences show up in three areas.
The category that gets the least attention during vendor selection, and causes the most regret later, is support quality. A few questions worth asking directly during evaluation:
The evaluation doesn't end once a provider looks good on paper. A few contract details determine how the relationship actually performs once it's signed.
BetterRX's approach to this is built around Top-Rated Client Support: a dedicated Client Success Manager backed by hospice-trained clinical experts, live support answered in about seven seconds on average, and a team that stays engaged through Quarterly Strategy Reviews rather than disappearing after implementation. That's paired with a Custom Tailored Pharmacy Alliance, a hospice-specific local pharmacy network built for speed and operational certainty, and transparent, pass-through pricing that keeps incentives aligned with the hospice rather than a pharmacy benefit manager's margin.
What this looks like in practice is a Client Success Manager who already knows a hospice's formulary preferences and staffing patterns before a question is even asked, rather than a support rep starting from zero on every call. That familiarity is what turns average response time into a meaningful number instead of just a marketing figure. Clients report similarly high satisfaction, 95%, with BetterRX Clinical Experts, which reflects how much of the day-to-day relationship depends on clinical, not just administrative, responsiveness.
That kind of feedback usually comes down to the parts of the relationship that don't show up in a sales deck: someone answers, the platform works the way it's supposed to, and problems get solved instead of escalated into a bigger issue.
For hospices planning to grow, whether through new locations, increased census, or acquisition, the pharmacy provider decision is also a scalability decision. A provider that can't standardize workflows and support across multiple sites becomes a bottleneck to growth rather than an enabler of it. BetterRX supports organizations ranging from independent hospices to large multi-state providers, and has served hospice organizations exclusively since 2007, which matters when evaluating whether a provider has actually operated at the scale a growing organization will eventually need.
This is also where reference calls pay off. A provider can describe its multi-location capabilities in the abstract, but a current client operating at a similar scale can describe what onboarding a third or fourth site actually felt like.
Even a well-researched decision can go sideways if the transition itself is mismanaged. Switching pharmacy providers introduces real short-term risk, and a few mistakes account for most of the trouble hospices run into.
Underestimating how long formulary and patient data transfer actually takes, and scheduling the switch during a busy census period instead of a quieter stretch.
Not confirming in writing how active patients' current medications will be handled during the transition window between providers.
Assuming staff will pick up a new ordering platform without dedicated training time, rather than building training directly into the transition plan.
Waiting until the new provider is fully live to test STAT and after-hours ordering, instead of confirming it works before the old provider's support ends.